News Breaks |
|
|
| January 3, 2013 |
| 16:20 EDT |  | ARAY | Accuray cites reasons for Q2 shortfall
The second fiscal quarterly results reflect a shortfall relative to expectations, which is attributable to challenges faced in two primary areas of the business: (1) manufacturing and supply related issues, which delayed contribution from new products launched at the 2012 Annual Meeting of the American Society for Radiation Oncology, ASTRO, and (2) commercial focus and salesforce transitional issues. |
|
|
News For ARAY From The Last 14 Days Check below for free stories on ARAY the last two weeks. |
|
|
| May 20, 2013 |
| 06:35 EDT | | ARAY | Millennium reports 4.98% passive stake in Accuray
 Subscribe for More Information |
|
| May 8, 2013 |
| 11:32 EDT |  | ARAY | High option volume stocks: LAMR AU CA ARAY OTEX
Subscribe for More Information |
|
| 09:00 EDT |  | ARAY | Accuray rises 13.2%
Accuray is up 13.2%, or 60c, to $5.15 |
|
| May 7, 2013 |
| 16:47 EDT |  | ARAY | Accuray lowers FY13 revenue outlook to $310M-$318M from $320M-$330M
Subscribe for More Information |
|
| 16:47 EDT | | ARAY | Accuray reports Q3 EPS (42c), consensus (22c)
Subscribe for More Information |
|
| May 6, 2013 |
| 16:33 EDT | | ARAY | Stelliam Investment Management reports 5.2% passive stake in Accuray
Subscribe for More Information |
|
|
|
|
|
